Activation of cyclic AMP phosphodiesterase by phorbol and protein kinase C pathway

Area of Science:

• Biochemistry
• Cellular Biology
• Endocrinology

Background:

• Insulin (INS) plays a crucial role in glucose metabolism and cellular signaling.
• Low Km cyclic AMP phosphodiesterase (PDE) regulates intracellular cyclic AMP (cAMP) levels.
• Diabetes mellitus is associated with altered metabolic pathways and cellular signaling.

Purpose of the Study:

• To investigate the effect of insulin and diabetes on low Km cAMP PDE activity.
• To explore the role of the inositide diacylglycerol-Ca++ pathway in PDE regulation.
• To identify common activation pathways for low Km cAMP PDE.

Main Methods:

• Enzyme activity assays were performed on rat adipose tissue.
• The effects of insulin, phorbol esters, and nifedipine on PDE activity were measured.
• Cyclic AMP (cAMP) levels in plasma and tissue were assessed in diabetic models.

Main Results:

• Insulin (INS) was found to stimulate low Km cAMP phosphodiesterase (PDE) activity.
• Diabetes was observed to inhibit low Km cAMP PDE activity, contributing to altered cAMP levels.
• Phorbol esters strongly stimulated PDE in rat adipose tissue, acting via protein kinase C and calcium.
• Nifedipine, a calcium channel blocker, inhibited insulin-stimulated PDE but not phorbol-stimulated PDE.

Conclusions:

• The study demonstrates novel effects of inositide diacylglycerol-Ca++ pathway components on PDE activity.
• Insulin and phorbol esters may share common pathways for activating low Km cAMP PDE.
• These findings provide insights into the regulation of cAMP metabolism in diabetes and cellular signaling.